DERMAZINC- pyrithione zinc cream 
WynnPharm Inc

----------

DermaZinc Cream

Pyrithione Zinc 0.25%

Keep Out of Reach of Children.

Seborrheic Dermatitis treatment

Apply to affected area twice daily or as directed by a doctor.

For relief of the symptoms of seborrheic dermatitis.

Warnings
■ For external use only.
■ Ask a doctor before use if you have a condition that covers a large area of the body.

When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with
water.
Stop use and ask a doctor if condition worsens or does not improve after regular use of this
product as directed.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

Inactive ingredients aloe barbadensis leaf (aloe vera gel) juice, carbomer, cetyl
alcohol, dimethicone, DMDM hydantoin, glyceryl stearate, isopropyl palmitate, methylparaben,
mineral oil, PEG-75 lanolin, sodium 1auryl sulfate, stearic acid, tocopheryl acetate (vitamin E),
triethanolamine,undecylenic acid, water

DermaZinc Cream

DERMAZINC 
pyrithione zinc cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:35324-001
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5) PYRITHIONE ZINC0.25 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
PEG-75 LANOLIN (UNII: 09179OX7TB)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
CARBOMER 980 (UNII: 4Q93RCW27E)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
DIMETHICONE 200 (UNII: RGS4T2AS00)  
GLYCERYL STEARATE SE (UNII: FCZ5MH785I)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
DMDM HYDANTOIN (UNII: BYR0546TOW)  
MINERAL OIL (UNII: T5L8T28FGP)  
WATER (UNII: 059QF0KO0R)  
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)  
TROLAMINE (UNII: 9O3K93S3TK)  
UNDECYLENIC ACID (UNII: K3D86KJ24N)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:35324-001-04114 g in 1 JAR; Type 0: Not a Combination Product08/29/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM03208/29/2022
Labeler - WynnPharm Inc (620885173)
Registrant - WynnPharm Inc (620885173)

Revised: 11/2023
Document Id: 0aefc951-f5b7-9535-e063-6394a90a54e8
Set id: e72e54ba-03fe-6748-e053-2a95a90a196f
Version: 2
Effective Time: 20231124
 
WynnPharm Inc